New test could highlight women at highest risk of recurring breast cancer

Testing for immune cell "hotspots" around tumours could help identify women at high risk of relapsing breast cancer, say scientists.

Women with large numbers of immune cells clustered in and around tumours were more likely to see their treatment fail within 10 years, research showed.